MedPage Today on MSN
Anti-VEGF agent collects big win in trial of diabetic retinopathy
More than 60% of tarcocimab-treated patients had reduced severity ...
People with advanced stages of retinopathy, even when glucose is very high, need to be very careful while controlling their ...
Many older adults complain about obstructions in their vision. These are called floaters in the eyes—something like tiny ...
A new study links spring daylight saving time changes to an up to 30% increased risk of retinal vascular disease.
REGENXBIO Inc. (Nasdaq: RGNX) today announced positive data from long-term follow-up studies of investigational surabgene lomparvovec (sura-vec, ABBV-RGX-314) in wet AMD using subretinal delivery and ...
Most Diabetic Patients With Atypical Renal Features Have Non-Diabetic Kidney Disease, Suggests Study
A recent retrospective study published in the Indian Journal of Nephrology in February 2026 reveals that 60.79% of diabetic ...
A new study published in The Journal of American Medical Association showed that during diabetic retinopathy screening, ...
REGENXBIO Inc. RGNX on Saturday shared long-term clinical trial findings for its experimental gene therapy surabgene ...
Treating diabetic retinopathy (DR) is still a significant challenge for clinicians and remains a leading cause of blindness worldwide. NovaGo Therapeutics is developing a human antibody therapy that ...
For the first time, Northwestern Medicine scientists have detailed how fall and spring daylight saving time transitions ...
Keeping our eyes healthy isn’t as hard as you might think. A few simple lifestyle changes are all it could take.
The WHO 2019 report on vision estimates that 36 million people in the world are blind and another 217 million have moderate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results